← All Sponsors
SPONSOR

Epygenix

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Dravet Syndrome
NCT04462770 Phase 3
Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Dravet Syndrome
United States, Canada, Georgia View Trial →